Consolidated Balance Sheets - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Current Assets
Cash	$ 473,921	$ 232,984
Trade accounts receivable, net	474,924	154,436
Inventory, net	130,530	61,051
Total Current Assets	1,079,375	448,471
Current Liabilities
Accounts payable and accrued expenses	408,194	167,481
Notes payable, net of discount	214,115	100,000
Total Current Liabilities	622,309	267,481
Immudyne, Inc. Stockholders' equity
Common stock, $0.01 par value; 50,000,000 shares authorized, 34,697,875 and 32,010,375 shares issued, 34,678,512 and 32,010,375 outstanding as of September 30, 2016 and December 31, 2015, respectively	346,978	320,103
Additional paid-in capital	9,032,728	8,366,313
Accumulated (deficit)	(9,075,014)	(8,586,338)
Equity	304,692	100,078
Treasury stock,19,363 shares, at cost	(4,720)
Total Immudyne, Inc. Stockholders' Equity	299,972	100,078
Non-controlling interest	157,094	80,912
Total Stockholders' Equity	457,066	180,990
Total Liabilities and Stockholders' Equity	$ 1,079,375	$ 448,471

It represents total of common stock, additional paid in capital and accumulated deficit.

No definition available.

Name:	immd_Equity
Namespace Prefix:	immd_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.